HMG and LGD-4033 Interaction
HMG and LGD-4033 have an interaction requiring monitoring for interaction with 51% confidence. Both HMG and LGD-4033 can elevate estrogen. Combined estrogenic load increases risk of gynecomastia, water retention, and mood changes. Monitor estradiol levels and consider AI if needed. Both compounds affect the gonads, so monitoring these systems is recommended.
Compound Profiles
HMG
Human Menopausal Gonadotropin | FSH/LH Fertility Hormone
HMG acts on gonadal tissue through two mechanisms: FSH stimulates growth and maturation of ovarian follicles containing eggs in women, and promotes spermatogenesis in men. LH stimulates ovulation and corpus luteum formation in women, and Leydig cells in men to produce testosterone.
View full profileLGD-4033
Selective Androgen Receptor Modulator | Lean Mass
LGD-4033 binds to the androgen receptor with high affinity (Ki of approximately 1 nM), functioning as a potent and selective agonist in muscle and bone tissue. Like other SARMs, its tissue selectivity is mediated by differential cofactor recruitment: upon binding to the AR, LGD-4033 induces a receptor conformation that preferentially recruits coactivators expressed in skeletal muscle and bone, while showing minimal agonist activity in androgen-sensitive tissues such as the prostate and skin.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take HMG with LGD-4033?
Yes, but with caution. Both HMG and LGD-4033 can elevate estrogen. Combined estrogenic load increases risk of gynecomastia, water retention, and mood changes. Monitor estradiol levels and consider AI if needed. Regular monitoring is advised.
Is HMG and LGD-4033 safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: estrogenic. Monitor accordingly.
What are the interactions between HMG and LGD-4033?
Both HMG and LGD-4033 can elevate estrogen. Combined estrogenic load increases risk of gynecomastia, water retention, and mood changes. Monitor estradiol levels and consider AI if needed. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time HMG and LGD-4033?
HMG has a half-life of ~32 hours (FSH component: 39-54 hours) and LGD-4033 has a half-life of ~24-36 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.